Access to talent, market drives global growth strategy for life science firms

Access to talent, market drives global growth strategy for life science firms

23 October, 2021

Esco Lifesciences Group MiRXES

Printed by Unregistered user on Sun, 27 Jul 2025 11:31:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Esco Lifesciences raises $200m in Vivo Capital, Novo Holdings-led round

Venture Capital

SG's MiRXES raises $77m Series C round led by CR-CP Life Science Fund

Read more from Singapore

Editor’s Take: The Week That Was—July 21-26

Beyond the Buyout: India exits show capital is flowing back to investors